Abstract
Oxidatively induced DNA damage is caused in living organisms by a variety of damaging agents, resulting in the formation of a multiplicity of lesions, which are mutagenic and cytotoxic.
Unless repaired by DNA repair mechanisms before DNA replication, DNA lesions can lead to genomic instability, which is one of the hallmarks of cancer. Oxidatively induced DNA damage is mainly repaired by base excision repair pathway with the involvement of a plethora of proteins. Cancer tissues develop greater DNA repair capacity than normal tissues by overexpressing DNA repair proteins. Increased DNA repair in tumors that removes DNA lesions generated by therapeutic agents before they became toxic is a major mechanism in the development of therapy resistance. Evidence suggests that DNA repair capacity may be a predictive biomarker of patient response. Thus, knowledge of DNA protein expressions in disease-free and cancerous tissues may help predict and guide development of treatments and yield the best therapeutic response. Our laboratory has developed methodologies that use mass spectrometry with isotope-dilution for the measurement of expression of DNA repair proteins in human and cultured cells. For this purpose, full length 15 N-labeled analogs of a number of human DNA repair proteins have been produced and purified to be used as internal standards for positive identification and accurate quantification. This article describes in detail the protocols of this work. The use of 15 N-labeled proteins as internal standards for the measurement of several DNA repair proteins in vivo is also presented.
INTRODUCTION
Exogenous and endogenous sources such as free-radicals and ionizing radiation generate oxidatively induced DNA damage by a variety of mechanisms, resulting in the formation of modified bases and sugars, DNA-protein cross-links, strand breaks, base-free sites, and tandem lesions such as 8,5'-cyclopurine-2'-deoxyribonucleosides and clustered damaged sites (reviewed in (Dizdaroglu & Jaruga, 2012 , Evans et al., 2004 ). This type of DNA damage is thought to play an important role in disease processes such as carcinogenesis and aging (reviewed in (Dizdaroglu, 2015 , Friedberg et al., 2006 ). Elaborate DNA repair pathways exist in mammalian cells with approximately 150 different proteins involved (reviewed in (Friedberg et al., 2006 , Wood et al., 2005 ). DNA repair deficiencies cause accumulation of DNA damage and mutations, leading to genomic instability, which is a major factor in carcinogenesis (Beckman & Loeb, 2005 , Hoeijmakers, 2001 , Kelley, 2012 , Liu et al., 2007 , Loeb, 2011 , Madhusudan & Middleton, 2005 . Oxidatively induced DNA damage is mainly repaired by base excision repair (BER) and also by nucleotide excision repair (NER), albeit to a lesser extent (Friedberg, Walker, Siede, Wood, Schultz, & Ellenberger, 2006) . In the first step of BER, DNA glycosylases hydrolyze the N-glycosidic bond releasing the damaged base and generating an abasic site, followed by the action of a series of other BER enzymes (Gros et al., 2002 , Hegde et al., 2008 . Formamidopyrimidine DNA glycosylase (Fpg, also called MutM) is one of the main DNA glycosylases in Escherichia coli, which specifically excises 4,6-diamino-5-formamidopyrimidine (FapyAde), 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua) and 8-hydroxyguanine (8-OH-Gua) from DNA containing multiple lesions (Boiteux et al., 1992 , Dizdaroglu, 2005 . In eukaryotes, 8-oxoguanine-DNA glycosylase (OGG1) including human OGG1 (hOGG1), which is a functional homolog of Fpg, exhibits a strong specificity for FapyGua and 8-OH-Gua, but does not act on FapyAde (Audebert et al., 2000 , Dherin et al., 1999 , Hu et al., 2005 , Sidorenko et al., 2009 ).
Mammalian NEIL1 protein, which is a E. coli Nei-like DNA glycosylase with an additional β,δ-elimination activity, has been discovered in eukaryotes (Bandaru et al., 2002 , Hazra et al., 2002 . This enzyme is unique in that it specifically removes FapyAde and FapyGua from DNA with multiple lesions, without exhibiting any significant activity for 8-OH-Gua (Bandaru et al., 2002 , Chan et al., 2009 , Doublie et al., 2004 , Hazra et al ., 2002 , Hu et al., 2005 , Jaruga et al., 2004 , Liu et al., 2010 , Muftuoglu et al., 2009 , Rosenquist et al., 2003 , Roy et al., 2007 . The involvement of NEIL1 in NER has also been suggested on the basis of accumulation of 8,5'-cyclopurine-2'-deoxyribonucleosides in neil1 -/-mice . Homologues of E. coli
Nth have also been found in yeast and mammals (Aspinwall et al., 1997 , Roldán-Arjona et al., 1996 . Mammalian NTH1 mainly acted on pyrimidine-derived lesions, exhibiting a narrower substrate specificity than E. coli Nth (Karahalil et al., 1998 , Roldán-Arjona et al., 1996 ; however, evidence has also been provided for purine-derived FapyAde to be the physiological substrate of NTH1 (Chan et al., 2009 , Hu et al., 2005 .
Other enzymes such as apurinic/apyrimidinic endonuclease 1 (APE1) and DNA polymerase β (Pol β) also plays vital roles in BER. Abasic sites, which are left behind following removal of modified DNA bases by DNA glycosylases, are processed by apurinic/apyrimidinic endonuclease 1 (APE1) (Demple et al., 1991) . APE1 provides over 95 % of the total apyrimidinic/apurinic endonuclease function with some additional critical functions (Abbotts & Madhusudan, 2010 , Barnes et al., 2009 , Demple et al., 1991 , Demple & Harrison, 1994 , Fishel et al., 2013 , Gros et al., 2004 , Tell et al., 2009 , Wilson, III & Barsky, 2001 , Xanthoudakis & Curran, 1992 . The action of APE1 generates a one-nucleotide gap with a 3'-OH and a 5'-terminal 2'-deoxyribose phosphate (dRP) moiety. Pol β, which is found in all vertebrate species (Beard & Wilson, 2006 , Beard & Wilson, 2014 , Braithwaite & Ito, 1993 , binds to this gap, and performs DNA synthesis with its DNA polymerase activity, filling in the gap. It then removes the blocking dRP-moiety, paving the way for other enzymes such as DNA ligases to close the resulting gap to complete the repair of DNA (Beard & Wilson, 2000 , Beard & Wilson, 2006 , Matsumoto & Kim, 1995 , Srivastava et al., 1998 .
Defects in BER enzymes such as those discussed above are associated with neurological disorders and cancer (Sampath et al., 2012 , Wallace et al., 2012 , Wilson, III et al., 2011 .
Polymorphic variants of these enzymes have been found in human populations in connection to various cancer incidences (reviewed in (Dizdaroglu, 2015) ). For example, neil1 -/-mice developed obesity and symptoms of metabolic syndrome (Vartanian et al., 2006) . Male and female neil1 -/-and nth1 -/-mice developed pulmonary and hepatocellular tumors to an extent up to ≈ 15 %. A dramatic increase up to 75 % in cancer incidence has been observed in neil1 -/-and nth1 -/-male and female mice (Chan et al., 2009) . In mice with both deleted alleles of ape1, early embryonic lethality has been observed; similarly, APE1 heterozygous mice exhibited increased oxidative stress, spontaneous mutagenesis and cancer incidences, and reduced survival of pups and embryos (Cabelof, 2012 , Hakem, 2008 , Huamani et al., 2004 , Meira et al., 2001 , Xanthoudakis et al., 1996 . Thus, accumulated evidence unequivocally points to the crucial role of BER enzymes in the maintenance of genetic stability and disease prevention.
It is now well known that overexpression of DNA repair proteins that may increase the DNA repair capacity is common in cancer , Kelley, 2012 , Madhusudan & Middleton, 2005 . Increased and effective DNA repair capacity in tumors that removes DNA lesions generated by ionizing radiation and/or chemotherapy before they became toxic is a major mechanism to develop therapy resistance. Evidence suggests that DNA repair capacity might be a predictive biomarker of patient response (Kelley, 2012 , Perry et al., 2012 . In this respect, BER proteins have emerged as biomarkers for assessment of the effectiveness and outcome of therapy (Chan & Bristow, 2010 , Curtin, 2013 , Fishel, Vascotto, & Kelley, 2013 , Helleday, 2008 , Illuzzi & Wilson, III, 2012 , Kelley, 2012 , Madhusudan & Middleton, 2005 , Moeller et al., 2010 , Perry et al., 2012 . Targeting MTH1 protein, which is not a BER protein, has been also suggested to be beneficial in cancer therapy (Gad et al., 2014 , Huber et al., 2014 .
This enzyme dephosporylates modified 2'-deoxynucleoside triphosphates in the nucleotide pool so that they cannot be incorporated into DNA during DNA replication, preventing cell death and mutations , Mo et al., 1992 , Sakai et al., 2002 , Sakumi et al., 1993 , Sekiguchi & Tsuzuki, 2002 , Tsuzuki et al., 2001 . Its overexpression has been observed in many cancers (Gad et al., 2014 , Huber et al., 2014 , Kennedy et al., 1998 , Okamoto et al., 1996 , Speina et al., 2005 .
The determination of the overexpression or underexpression of DNA repair proteins in normal and cancer tissues may help predict and guide development of treatments, potentially yielding the greatest therapeutic response (Kelley, 2012 (Coskun et al., 2015 . Stable isotope-labeled analogs of DNA repair proteins, which are to be used as internal standards, were produced, purified and characterized. This article describes the procedures used for this purpose and the application of the developed internal standards for the measurement of DNA repair proteins.
MATERIALS AND METHODS

Materials
Restriction endonucleases, DNA ligase, and calf intestinal alkaline phosphatase were obtained 
Escherichia coli strains and plasmids
The pET11a expression vector, for native protein production of EcFpg based on the IPTG induction, was obtained from Navagen, Madison, WI. The relevant strains for cloning and expression are E. coli Novablue (K12) and BL21(DE3), respectively. The human ogg1 gene in the expression vector pET15b for his-tagged production of the protein was kindly provided by Dr. Dmitry Zharkov through Prof. Arthur Grollman's laboratory. The human neil1 gene in the expression vector pET28 for His-tagged production of the protein was kindly provided by Dr.
Stephen Lloyd (Oregon Health and Science University, Portland, Oregon). The human ape1 gene was provided by Dr. David M. Wilson III of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Preparation of minimal medium
The composition of the medium was: 6 g NaH2PO4, 3 g K2HPO4, 0.5 g NaCl, and 1 g 15 NNH4Cl, 5 g glucose, 246 mg MgSO4.7H2O per liter. Ampicillin or kanamycin was added to a final concentration of 50 µg/mL or 25 µg/mL, respectively.
DNA procedures
E. coli Novablue (K12) harboring a recombinant plasmid was grown at 37 o C overnight in 10 mL Luria-Bertani medium (Miller, 1972) , containing the appropriate antibiotic.
Minipreparations of plasmid DNA were purified using a Qiagen Kit. Digestion of DNA with restriction enzymes was performed according to the manufacturer's recommendation. DNA fragments were separated by electrophoresis on SeaKem GTG agarose or NuSieve GTG agarose. DNA was purified using a Qiagen Kit. Ligation of DNA fragments was performed as described (Sambrook et al., 1989) . Competent cells of the E. coli strains used here were prepared by the Hanahan method (Hanahan, 1983 , Sambrook et al., 1989 .
PRODUCTION AND PRUFICATION OF E. COLI 15 N-FPG PROTEIN
Cloning of fpg into pET11a vector
The coding sequence for E. coli Fpg gene from the plasmid pFpg was provided by Dr. Timothy R. mmol/L β-mercaptoethanol, pH 7.5. Protein concentration was determined by the Lowry method using BSA as standard (Lowry et al., 1951) . is shown in Figure 1 , indicating high purity of the labeled protein . 
PRODUCTION AND PURIFICATION OF
Purification of 15 N-hOGG1
The cell pellet was suspended in 20 mL of 50 mmol/L Tris-Cl, pH: 8.0, 10 mmol/L β-mercaptoethanol, 300 mmol/L NaCl, and 10 mmol/L imidazole (lysis buffer 2) containing one tablet of protease inhibitors. Cell suspension was passed through a French Press at 7.1 x10 4 kPa.
The cell-free extract was centrifuged at 40000 x g for 1 h. Meanwhile, 2 mL of nickel-agarose slurry (1mL resin) was washed with the lysis buffer 2 in a 30 mL Bio-Rad polypropylene column. The supernatant was added to the resin and mixed on a rocker for 2 h at 4 o C. The flow through was collected, and the column was washed successively with three 10 mL aliquots of the lysis buffer 2. Next, the resin was washed three times with 3 mL aliquots of the lysis buffer 2 containing an additional 20 mmol/L imidazole (total 30 mmol/L). Next, the hOGG1 was eluted with five 5 mL aliquots of the lysis buffer containing 100 mmol/L imidazole. The first 5 mL contained about 50 % of hOGG1 (≈95 % pure) with minor contaminants as judged by SDS-PAGE. The subsequent four elutions contained the remaining hOGG1 with higher purity (≈98 %). All the five elutions containing hOGG1 were pooled, concentrated on YM3 membrane filter, and dialyzed overnight against 500 mL of 50 % glycerol, 20 mmol/L Tris-Cl, 1 mmol/L EDTA, and 10 mmol/L β-mercaptoethanol, pH 7.5. Mass measurements and activity analysis of 15 NhOGG1 was carried out. Protein concentration was determined by the Lowry method using BSA as standard (Lowry et al., 1951) . Total yield of the protein was 5.3 mg. Figure 2 shows the SDS-PAGE and Coomassie staining of 15 N-hOGG1 (lane 5) and protein molecular mass standards (lane 6), indicating high purity of the labeled protein. .
PRODUCTION AND PURIFICATION OF 15 N-hNEIL1
Production of 15 N-hNEIL1
E. coli BL21 (DE3) harboring pET28 / human neil1 recombinant plasmid was grown at 37 °C for 20 h on LB agar plate containing 100 µg ampicillin and 40 µg chloramphenicol /mL. A colony was carefully (without touching into the LB medium) transferred to 10 mL minimal medium containing 1 mg 15 N-NH4Cl/mL and 50 µg ampicillin and 20 µg chloramphenicol/mL. Cells were grown for 16 h at 37 °C at 250 rpm in a 50 mL tube. This inoculum was transferred to 90 mL minimal medium, in a 250 mL flask, containing 15 N-NH4Cl, ampicillin, and chloramphenicol as above. This culture was grown at 37 °C for 9 h. Next, this seed culture was transferred to 900 mL of minimal medium containing 15 N-NH4Cl, ampicillin, chloramphenicol in a 2 L flask. This culture was grown at 37 °C for 4 h. Cells (A600 = 0.45) were briefly cooled in ice and 15 NhNEIL1 production was induced with 100 µmol IPTG/mL at 25 °C for 16 h. Cells were harvested at 6000 x g for 20 min and washed with 25 mmol/L Tris buffer (pH 7.5). The wet weight of cells obtained in this procedure was 2.8 g/L culture.
Purification of 15 N-hNEIL1
Cell pellet was suspended at a rate of 1 g/10 mL of 50 mmol/L Na2HPO4-NaH2PO4 buffer (pH 8.0), 10 mmol/L β-mercaptoethanol, 10 mmol/L imidazole, and 300 mmol/L NaCl (lysis buffer ).
One tablet of protease inhibitors was added to the cell suspension. Cell suspension was passed through a French Press at 7.1 x10 4 kPa twice. The cell-free extract was centrifuged at 36000 x g for 30 min. Meanwhile, 1 mL of nickel-agarose slurry (0.5 mL resin) was washed with the lysis buffer in a 30 mL Bio-Rad polypropylene column. The supernatant was added to the resin and mixed on a rocker for 2 h at 4 °C. The flow through was collected, and the column was washed successively with three 10 mL aliquots of the lysis buffer. Next, the resin was washed successively two times with 10 mL aliquots of the lysis buffer containing an additional 30 mmol/L imidazole (total 40 mmol/L). Next, the resin was washed successively three times with 5 mL aliquots of the lysis buffer containing an additional 70 mmol/L imidazole (total 80 mmol/L). Protein concentration was determined by the Lowry method using BSA as the standard (Lowry et al., 1951) . The final yields of 15 N-hNEIL1 was ≈2 mg/L culture. The SDS-PAGE and Coomassie staining of 15 N-hNEIL1 (lane 5) and protein molecular mass standards (lane 6), is presented in Figure 3 . A high purity of the labeled protein can be seen with a minor contaminant at ≈17 kDa .
PRODUCTION AND PURIFICATION OF 15 N-hAPE1
Production of 15 N-hAPE1
E. coli BL21 (DE3) harboring pET11/hAPE1 recombinant plasmid was grown at 37 °C for 20 h on LB agar plate containing 100 µg ampicillin/mL. A colony was carefully (without touching into the LB medium) transferred to 10 mL minimal medium containing 50 µg ampicillin/mL.
Cells were grown for 3 h at 37 °C at 250 rpm in a 50 mL tube. This inoculum was transferred to 200 mL minimal medium with 50 µg ampicillin/mL in a 500 mL flask. This culture was grown at 37 °C for 14 h. Next, each 50 mL of this seed culture was transferred to 4 x 1000 mL of minimal medium containing 15 N-NH4Cl and ampicillin in 4 x 2 L flasks. This culture was grown at 37 °C for 6 h and then at 20 °C for 90 min. Cell density at this stage was A600 = 0.5. The production of 15 N-hAPE1 was induced with 100 µmol IPTG / mL at 20 °C for 15 h. Cells were harvested at 6000 x g for 20 min and washed with 25 mmol/L Tris buffer (pH 7.5). The wet weight of cells obtained in this procedure was 2.25 g/L culture for a total of 9 g wet weight of cells.
Purification of 15 N-hAPE1
Nine .
PRODUCTION AND PURIFICATION OF 15 N-hMTH1
15 N-hMTH1 was produced according to the procedures used for the production of hMTH1 (Svensson et al., 2011) . 15 N-hMTH1 was expressed from pET28a-hMTH1 in E.coli BL21 (DE3) grown in a minimal medium (6 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 5 g glucose, 120.4 mg Figure 5 illustrates the SDS-PAGE analysis of 15 NhMTH1 along with hMTH1 and protein standards, indicating high purity of both proteins (Coskun et al., 2015) .
MASS SPECTROMETRIC ANALYSIS OF 15 N-LABELED PROTEINS
Mass spectrometry was used to measure the molecular masses and to check the isotopic purities of 15 N-labeled DNA repair proteins that were produced as described above. MALDI-ToF mass spectrometry was applied to measure the molecular masses of E. coli 15 N-Fpg and 15 NhOGG1 Considering that the MALDI-ToF mass spectrometry provides a mass accuracy of 0.1 %, these values represent more than 99 % 15 N-labeling of E. coli Fpg, hOGG1 and hNEIL1 proteins.
An Orbitrap mass spectrometer coupled to an HPLC system, which has a mass accuracy of 0.001 %, was used to measure the molecular mass of 15 N-hAPE1 . The As an example of full scan mass spectra, Figure 6 illustrates the mass spectrum of one of the tryptic peptides of hAPE1 and its 15 N-labeled analog . In general, mass spectra of such peptides contain an MH + ion of lower abundance (ion at m/z 1131 in Figure   6 ) and a doubly protonated (charged) molecular ion [(M+2H) 2+ ] as the most abundant ion (m/z 566.1 in Figure 6 ) (Kinter & Sherman, 2000) . The mass spectrum of the 15 N-labeled peptide exhibited a shift of 14 Da in the mass of MH + of the unlabeled peptide, consistent with the fourteen 15 N atoms in the molecule. The shift in the mass of (M+2H) 2+ was also in agreement with the mass difference of 14 Da. To obtain product ion spectra, optimum collision energies using (M+2H) 2+ ions as the precursor ions were measured (Coskun et al., 2015 . These were in agreement with previously determined collision energies of peptides with similar masses (Kinter & Sherman, 2000) . Product ion spectra of identified tryptic peptides were recorded using the determined collision energy for each peptide. As examples, product ion spectra of the peptides in Figure 6 are illustrated in Figure 7 ( Kirkali et al., 2013) . Such spectra are generally dominated by so-called y-series ions with b-series ions being of lesser intensity (Kinter & Sherman, 2000) . In Figure 7A , typical y-ions from the y1-ion to the y9-ion, with the most co-eluted at the same retention time , Coskun et al., 2015 . To further ascertain the identity of a target peptide, multiple typical transitions were simultaneously monitored. All typical transitions of tryptic peptides lined up at their appropriate retention times, confirming their identity. The analytical sensitivity of the LC-MS/MS instrument was measured. Depending on the peptide, the on-column limit of detection varied from 10 fmol to 20 fmol with a signal-to-noise ratio of at least 3, whereas the limit of quantification was approximately 50 fmol to 100 fmol of target peptide with a signal-to-noise ratio of 10.
Measurement of DNA repair proteins in vivo
hAPE1 has been positively identified and quantified in nuclear and cytoplasmic extracts of three human cell lines and in mouse liver , and in human cancerous and disease-free breast tissues (unpublished data). Different expression levels of hAPE1 were observed depending of which occur in several cancers (Pieretti et al., 2001) , and in the general population (Hadi et al., 2000 , Mohrenweiser et al., 2002 .
hMTH1 has been unequivocally identified and quantified in human malignant and disease-free breast tissues, and in four cultured human cell lines (Coskun et al., 2015) . Extreme expression of MTH1 in malignant breast tumors was observed, suggesting that cancer cells are addicted to MTH1
for their survival. In agreement with this finding, cultured MCF-7 cells exhibited a much greater expression level of hMTH1 than their normal counterpart mammary gland epithelial (MCF-10A) cells.
CONCLUSIONS
In this chapter, we describe the production and purification of full length NhMTH1; Lane 7, Molecular mass markers (data from (Coskun et al., 2015) ). ). ). 
